- Price is above the Trend Line, keeping the weekly tape constructive.
- Next-week expectancy is positive at 56.41% based on similar historical setup states.
DRMA
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Dharma Polimetal Tbk · Consumer Cyclical · Auto Parts
Latest close
960.0 IDR
0.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 1.1% above the Trend Line and sits at 39.8% of its 52-week range. The latest completed week returned 0.0%, after a 6.7% four-week move. The latest news-sentiment score is 38/100. Near-term considerations: volume confirmation is below normal.
Setup score
56
out of 100
Latest Close
960.0 IDR
7 Aug 2026
1W Return
0.0%
latest completed week
4W Return
6.7%
short-term follow-through
12W Return
-3.0%
quarterly tape
Trend Breadth
57.7%
30 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.0%
Latest completed week; four-week move 6.7%.
Indicator stack
32/36
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 56.41%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
38/100
7 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.1% above the Trend Line and sits at 39.8% of its 52-week range. The latest completed week returned 0.0%, after a 6.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2612-week average 0.47
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.26Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.7% over four weeks, -3.0% over 12 weeks, and 7.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year30
Trend breadth57.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.71Latest activity-pressure read.
Pressure change-16.3%Four-week change in activity pressure.
Leadership16.99Latest relative-leadership reading.
RS change-18.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment38/100
Weighted news tone is negative across 7 relevant articles.
1 positive · 5 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.3%Distance below the 52-week high.
13-week volatility2.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 269 weeks finished lower.
Best week+6.1%Week of 31 Jul.
Worst week-7.5%Week of 6 Mar.
Latest week+0.0%Week of 7 Aug.
Shape of recent returns
Strong gains1
Modest gains12
Flat weeks4
Modest losses7
Sharp losses2
Recent vol2.5%13-week weekly-return volatility.
Base vol3.1%52-week weekly-return volatility.
Up/down split24/23Count of positive and negative weeks in the 52-week window.
Average skew2.7% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Consumer Cyclical
4-week rank44 / 100
Group average8.6%
Trend breadth13.0%
Trend13.0%active weekly trend signals
MD46.0%positive activity pressure
RS65.0%positive relative leadership
Four-week leaders
IndustryID Auto Parts
4-week rank4 / 12
Group average6.0%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD41.7%positive activity pressure
RS83.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis41/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 12/12.
Activity pressure 0.26; No reversal markers Next-Week ExpectancyPositive 56.41%Next-week expectancy is positive with a 56.41% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment38/100Weighted news tone is negative across 7 relevant articles.
DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 960.0 IDR | 0.0% | 949.5 IDR | 971.7 IDR | -0.71 | 16.99 | 2.6M | Off |
| 31 Jul 2026 | 960.0 IDR | 6.1% | 950.6 IDR | 974.2 IDR | -0.87 | 20.81 | 2.3M | Off |
| 24 Jul 2026 | 905.0 IDR | -1.6% | 951.3 IDR | 976.6 IDR | -1.02 | 15.25 | 3.6M | Off |
| 17 Jul 2026 | 920.0 IDR | 2.2% | 953.9 IDR | 978.2 IDR | -0.92 | 18.00 | 2.0M | Off |
| 10 Jul 2026 | 900.0 IDR | 1.1% | 955.6 IDR | 980.2 IDR | -0.61 | 20.80 | 2.9M | Off |
| 3 Jul 2026 | 890.0 IDR | 0.0% | 959.4 IDR | 982.3 IDR | -0.37 | 20.91 | 80.6K | Off |
| 26 Jun 2026 | 890.0 IDR | -4.8% | 962.7 IDR | 984.9 IDR | -0.12 | 20.88 | 558.2K | Off |
| 19 Jun 2026 | 935.0 IDR | -0.5% | 965.2 IDR | 987.1 IDR | 0.15 | 21.61 | 9.0M | Off |
| 12 Jun 2026 | 940.0 IDR | -3.6% | 966.2 IDR | 988.1 IDR | 0.20 | 26.14 | 413.0K | Off |
| 5 Jun 2026 | 975.0 IDR | 0.0% | 966.2 IDR | 987.9 IDR | 0.32 | 41.11 | 1.7M | Off |
| 29 May 2026 | 975.0 IDR | -1.0% | 966.0 IDR | 987.7 IDR | 0.40 | 29.73 | 7.0M | Off |
| 22 May 2026 | 985.0 IDR | -0.5% | 966.2 IDR | 987.1 IDR | 0.42 | 30.92 | 7.3M | Off |
| 15 May 2026 | 990.0 IDR | 0.5% | 964.8 IDR | 986.8 IDR | 0.37 | 21.07 | 3.0M | Off |
| 8 May 2026 | 985.0 IDR | 0.5% | 961.7 IDR | 986.4 IDR | 0.16 | 16.48 | 6.2M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.